Averto Medical Awarded $2.1 Million NIH Grant to Advance Breakthrough Therapy for Diverticulitis
SAN FRANCISCO, Oct. 6, 2025 /PRNewswire/ — Averto Medical, a clinical-stage medical technology company pioneering gastrointestinal disease solutions, today announced it has been awarded a $2.1 million grant from the National Institutes of Health (NIH) to study its flagship product,... Read More →
Every Centimeter Counts: Eclipse Regenesis Gives Toddler with SBS a Second Chance
Lydia Garcia’s first two years were marked by severe medical crises, including multiple emergency operations after a twisted intestine caused most of her small bowel to die. After months on intravenous nutrition, her Stanford surgeon, Dr. James Dunn, preserved a... Read More →
Ryght AI Assembles Renowned Medical Leaders to Guide Next Phase of Clinical Trial AI Innovation
Ryght’s distinguished board of scientific experts will guide the company’s research initiatives and strategic direction as it transforms clinical trial site selection, qualification, and activation through dynamic digital replicas of research facilities globally. LAGUNA BEACH, Calif., Oct. 7, 2025 /PRNewswire/... Read More →
PharmaJet®, a World Leader in Needle-free Injection Systems, is Initiating the Development of Needle-free Self-Injection Pens for Home Use
Single-use and reusable needle-free injection devices will be designed for precise self-administration and home use. PharmaJet injector pens are intended for needle-free subcutaneous delivery of a wide range of pharmaceuticals, which could include metabolic peptides, hormones, small molecules, and antibodies.... Read More →
HeartX Cardiovascular Accelerator Announces Seven Startup Companies Selected for the 2025 Program featuring CardiaCare, CathVision, Dopl Technologies, Fibricheck, and LiveMetric
HeartX, powered by HealthTech Arkansas and MedAxiom — along with dozens of leading cardiovascular programs around the country — has selected the seven startup healthcare companies that will participate in the 2025 accelerator program. HeartX is a cardiovascular-focused healthcare accelerator... Read More →
ACORAI Presents Positive Results in 1,600-Patient CAPTURE-HF Study for its AI-Powered Non-Invasive Multi-Sensor Platform for Improved Heart Failure Patient Management
MINNEAPOLIS, Oct. 6, 2025 /PRNewswire/ — Acorai, a clinical-stage company pioneering non-invasive hemodynamic monitoring for heart failure management, this week announced topline results from the 1,600-patient CAPTURE-HF study (Machine-Learning Estimation of Pulmonary Capillary Wedge and Right Atrial Pressures With a... Read More →
AtaCor Medical Secures $75M Financing to Support the Pivotal U.S. Study of its Extravascular ICD (EV-ICD) System
The novel design of AtaCor’s Atala™ lead aims to provide reliable sensing, antitachycardia pacing (ATP), and shock therapies with no hardware placed in the heart or vasculature SAN CLEMENTE, Calif., Oct. 6, 2025 /PRNewswire/ — AtaCor Medical, Inc., a privately-held... Read More →
JPY 1.3 Billion Raised in Series B2 Funding, Pushing B dot Medical’s Total Capital to JPY 6.8 Billion
B dot Medical Inc. (Headquarters: Edogawa-ku, Tokyo; CEO: Takuji Furukawa; “B dot Medical”) announced today that it has successfully closed its Series B2 financing round, raising JPY 1.3 billion. The funds were secured through a third-party allocation of shares utilizing... Read More →
DermaSensor Secures $16M to Scale AI-Powered Skin Cancer Detection in Primary Care
MIAMI, FL – October 2, 2025 / EINPresswire.com/ DermaSensor Inc., a medical device technology company transforming skin cancer detection for frontline care, today announced it has raised $16 million in Series B funding to fuel the commercial expansion of its... Read More →
Precision Cell Systems Acquires BennuBio to Enter the 3D Cell Culture Market
LIVERMORE, Calif., Oct. 1, 2025 /PRNewswire/ — Precision Cell Systems (PCS) today announced the acquisition of BennuBio, marking a significant entry into the rapidly growing 3D cell culture market. According to Grand View Research, the global market was valued at... Read More →